Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04476225 · ClinicalTrials.gov registry record
Induced Pluripotent Stem Cells for Disease Research
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 1
- Enrollment target
NCT04476225 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 1 participants.
The verdict
NCT04476225 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The aim of this study is to determine the contribution of genetic factors to the pathogenesis of diseases, including diseases such as Parkinson's disease, Hirschsprung's disease, and autism. Patient-derived cellular models of diseases will be developed, which will require the collection of blood samples from patients and healthy individuals in order to generate induced pluripotent stem cells (iPSCs) for the development of iPSC-derived human cell cultures. These human cellular models will be phenotyped using a variety of methods, including cellular, molecular, and biochemical assays. Because these human cellular models will retain the genetic background from the patients and control subjects, this will allow us to determine the contribution of genetics to disease phenotypes. Such disease-specific pluripotent stem cell lines will be invaluable tools for many basic and translational research applications, including pathophysiological studies in a developmental context, and innovation and screening of small molecule drugs capable of reversing the disease phenotype and potentially leading to a cure for a broad range of diseases, where appropriate in vitro or in vivo disease models do not exist.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2022-10-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04476225
The ClinicalTrials.gov registry entry for NCT04476225 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04476225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04476225 about?
NCT04476225 is a clinical study titled "Induced Pluripotent Stem Cells for Disease Research". The aim of this study is to determine the contribution of genetic factors to the pathogenesis of diseases, including diseases such as Parkinson's disease, Hirschsprung's disease, and autism. Patient-derived cellular models of diseases will be developed, which will require the collection of blood sam...
What is the current status of trial NCT04476225?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2022-04-15. Estimated completion is 2022-10-03.
Who is sponsoring clinical trial NCT04476225?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.